Related Experiment Video
Updated: Jun 25, 2026

Light-sheet Fluorescence Microscopy to Capture 4-Dimensional Images of the Effects of Modulating Shear Stress on the Developing Zebrafish Heart
Published on: August 10, 2018
RhoGDIbeta-induced hypertrophic growth in H9c2 cells is negatively regulated by ZAK
Chih-Yang Huang1, Li-Chiu Yang, Kuan-Yu Liu
1Graduate Institute of Chinese Medical Science, China Medical University, Taichung 404, Taiwan. cyhuang@mail.cmu.edu.tw
Insights
Rho GDP dissociation inhibitor beta (RhoGDIbeta) overexpression causes hypertrophic growth. Its interaction with ZAK kinase, which phosphorylates RhoGDIbeta, regulates cell growth and cycle progression.
Area of Science:
- Cell biology
- Molecular biology
- Cardiovascular research
Background:
- Rho GDP dissociation inhibitors (RhoGDIs) regulate Rho GTPases, crucial for cell functions.
- RhoGDIbeta's role in cardiomyocyte growth and cell cycle control is not fully understood.
- ZAK kinase is implicated in stress responses and cell proliferation.
Purpose of the Study:
- To investigate the role of RhoGDIbeta in cardiomyocyte hypertrophy and cell cycle progression.
- To elucidate the interaction between RhoGDIbeta and ZAK kinase.
- To determine the regulatory mechanism between ZAK and RhoGDIbeta.
Main Methods:
- Overexpression and RNA interference (RNAi) in cultured cardiomyoblasts.
- In vitro kinase assays to study ZAK-RhoGDIbeta interaction and phosphorylation.
- Western blotting to assess protein levels and phosphorylation status.
Main Results:
- RhoGDIbeta overexpression induced hypertrophic growth and suppressed cell cycle progression.
- RhoGDIbeta knockdown blocked hypertrophic growth.
- ZAK phosphorylates RhoGDIbeta, negatively regulating its function.
- Physical interaction between ZAK and RhoGDIbeta maintains ZAK in an inactive state.
- ZAK knockdown restored RhoGDIbeta function.
Conclusions:
- RhoGDIbeta plays a critical role in regulating cardiomyocyte size and cell cycle.
- ZAK kinase negatively regulates RhoGDIbeta activity through phosphorylation.
- A reciprocal inhibitory relationship exists between ZAK and RhoGDIbeta.
- Targeting the ZAK-RhoGDIbeta pathway may offer therapeutic strategies for cardiac hypertrophy.
Abstract:
We found that overexpression of RhoGDIbeta, a Rho GDP dissociation inhibitor, induced hypertrophic growth and suppressed cell cycle progression in a cultured cardiomyoblast cell line. Knockdown of RhoGDIbeta expression by RNA interference blocked hypertrophic growth. We further demonstrated that RhoGDIbeta physically interacts with ZAK and is phosphorylated by ZAK in vitro, and this phosphorylation negatively regulates RhoGDIbeta functions. Moreover, the ZAK-RhoGDIbeta interaction may maintain ZAK in an inactive hypophosphorylated form. These two proteins could negatively regulate one another such that ZAK suppresses RhoGDIbeta functions through phosphorylation and RhoGDIbeta counteracts the effects of ZAK by physical interaction. Knockdown of ZAK expression in ZAK- and RhoGDIbeta-expressing cells by ZAK-specific RNA interference restored the full functions of RhoGDIbeta.
Related Concept Videos
Cellular Adaptation II: Hypertrophy
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
Negative Regulator Molecules
Small GTPases - Ras and Rho
Three regulatory proteins control their activity: